LIGAND PHARMACEUTICALS INC — Director's Dealing 2011

Feb 10, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LIGAND PHARMACEUTICALS INC (LGND)
CIK: 0000886163
Period of Report: 2011-02-07

Reporting Person: LAMATTINA JOHN L (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-02-07	Common Stock	A	1666	—	Acquired	1666	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-02-07	Non-Qualified Stock Option (right to buy)	$8.97	A	5000	Acquired	2014-02-07	Common Stock (5000)	Direct

Footnotes

F1: The option becomes exercisable in 36 successive equal monthly installments upon completion of each calendar month of service beginning on the grant date.